Nuveen Asset Management, LLC Anavex Life Sciences Corp. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 178,965 shares of AVXL stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

178,965

Previous 304,165 41.16%

Holding current value

$2.01 Million

Previous $1.28 Million 20.81%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.11 - $7.04 $514,572 - $881,408	-125,200 Reduced 41.16%	178,965 $1.02 Million
Q2 2024 Aug 09, 2024	BUY	$3.39 - $5.02 $130,084 - $192,632	38,373 Added 14.44%	304,165 $1.28 Million
Q1 2024 May 13, 2024	BUY	$4.55 - $6.75 $115,347 - $171,119	25,351 Added 10.54%	265,792 $1.35 Million
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $69,647 - $137,499	13,819 Added 6.1%	240,441 $2.24 Million
Q3 2023 Nov 14, 2023	BUY	$6.55 - $9.37 $92,715 - $132,632	14,155 Added 6.66%	226,622 $1.48 Million
Q2 2023 Aug 14, 2023	BUY	$7.66 - $9.5 $8,157 - $10,117	1,065 Added 0.5%	212,467 $1.73 Million
Q1 2023 May 15, 2023	SELL	$8.32 - $11.75 $80,520 - $113,716	-9,678 Reduced 4.38%	211,402 $1.81 Million
Q4 2022 Feb 14, 2023	SELL	$7.65 - $14.43 $385,368 - $726,911	-50,375 Reduced 18.56%	221,080 $2.05 Million
Q3 2022 Nov 14, 2022	SELL	$8.9 - $12.86 $31,817 - $45,974	-3,575 Reduced 1.3%	271,455 $2.8 Million
Q2 2022 Aug 15, 2022	BUY	$7.31 - $12.84 $9,495 - $16,679	1,299 Added 0.47%	275,030 $2.75 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $288,333 - $523,677	29,603 Added 12.13%	273,731 $3.43 Million
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $311,604 - $430,302	18,460 Added 8.18%	244,128 $4.23 Million
Q3 2021 Nov 12, 2021	SELL	$16.82 - $25.75 $153,903 - $235,612	-9,150 Reduced 3.9%	225,668 $4.05 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $28.86 $170,576 - $484,530	-16,789 Reduced 6.67%	234,818 $5.37 Million
Q1 2021 May 17, 2021	BUY	$5.17 - $16.13 $258,060 - $805,128	49,915 Added 24.75%	251,607 $3.76 Million
Q4 2020 Feb 16, 2021	BUY	$4.01 - $7.58 $6,436 - $12,165	1,605 Added 0.8%	201,692 $1.09 Million
Q3 2020 Nov 16, 2020	BUY	$3.8 - $5.0 $3,454 - $4,545	909 Added 0.46%	200,087 $910,000
Q2 2020 Aug 14, 2020	SELL	$2.62 - $5.2 $32,781 - $65,062	-12,512 Reduced 5.91%	199,178 $980,000
Q1 2020 May 14, 2020	BUY	$2.38 - $5.81 $241,558 - $589,685	101,495 Added 92.1%	211,690 $666,000
Q2 2019 Aug 15, 2019	BUY	$2.75 - $3.7 $303,036 - $407,721	110,195 New	110,195 $372,000

Others Institutions Holding AVXL

# of Institutions

157

Shares Held

27.4M

Call Options Held

515K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $875M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Anavex Life Sciences Corp. Transaction History